anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Evidence

Beat collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 40,452
Current window 23,641-23,670
Pages 1,349
Rows per page 30
Beat: Evidenceclear collectionreset all
18 30 60

Beat

23,641-23,670 of 40,452

filter-aware
25
Contains detailed footnotes explaining the methodology for calculating outflows and flows.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
26
Includes detailed footnotes explaining share issuance for acquisitions, share repurchase methodology, and remaining authorization.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
10
The slide outlines the study structure for a clinical trial, categorizing cohorts by dosage and patient status (HBV DNA +/-).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
11
Data table includes standard error (SE) values for each mean. Footnote provides specific study parameters.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
12
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, with specific callouts for individual patient outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
13
The slide displays 8 individual patient charts tracking three biomarkers over 64 weeks. Two patients (53 and 58) show NA retreatment periods.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
14
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
15
The slide uses a bulleted list to present clinical safety findings.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
16
The slide uses a four-column layout to present key findings from a clinical trial.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
06
Astra | Results Presentation Deck | 23 slidesAstra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
07
The slide serves as a visual anchor for the company's manufacturing capabilities.Astra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
08
Astra | Results Presentation Deck | 23 slidesAstra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
09
The slide uses a visual contrast between the hardware (left) and the operational benefits (right).Astra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
10
Astra | Results Presentation Deck | 23 slidesAstra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
11
The slide features the Astra logo and a high-quality photograph of a thruster firing.Astra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
12
Astra | Results Presentation Deck | 23 slidesAstra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
13
The slide uses icons to represent specific satellite operations: Orbit Raising, Station Keeping, Collision Avoidance, and De-orbiting.Astra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
14
The slide uses a 3D render of the engine with callouts pointing to specific hardware components.Astra | Results Presentation Deck | 23 slides · Astra
Conference presentation Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style visualization to represent drug development stages.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Beat · Business Model1 hit
03
Azek | Results Presentation Deck | 15 slidesAzek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · Evidence1 hit
04
The slide uses a classic 'temple' metaphor to represent strategic pillars.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
05
Includes two distinct sections: Financial Highlights and Operational & Commercial Highlights.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
02
The slide uses a visual funnel/progression metaphor to link user growth to market size.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
07
The slide uses a map background to emphasize the global nature of the platform.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Business Model1 hit
08
The slide includes a bar chart for revenue, a donut chart for revenue split, and a list of value drivers.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Business Model1 hit
09
The slide uses a value-chain style flow to map demand sources to supply channels via a central adtech platform.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Business Model1 hit
15
The table highlights key non-GAAP financial metrics including revenues, margins, operating expenses, and cash flows.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
16
Includes footnotes regarding non-GAAP measures and debt definitions.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
17
Includes a callout highlighting no debt maturities until 2025 for specific segments.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
18
The chart includes a callout box summarizing total debt, restricted vs. unrestricted portions, and a recent reduction in restricted debt.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit